BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023)

BioCorRx (BICX) posted Asset Writedowns and Impairment of $47980.0 for Q1 2023, up 1311.18% sequentially from $3400.0 in Q2 2019.

BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023) Analysis & Trends

BioCorRx (BICX) has 6 years of Asset Writedowns and Impairment data on file, last reported at $47980.0 in Q1 2023.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $47980.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $47980.0 (changed N/A YoY) and the FY2023 annual result came in at $47980.0, changed N/A from the prior year.
Asset Writedowns and Impairment improved to $47980.0 in Q1 2023 per BICX's latest filing, from $3400.0 in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $47980.0 in Q1 2023, with the low at -$1000.0 in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	87.94 Bn	90.32 Bn	16.26 Bn
2	Chemed	18.08 Bn	18.07 Bn	215.76 Mn
3	Tenet Healthcare	16.59 Bn	15.76 Bn	4.41 Bn
4	Davita	15.37 Bn	16.23 Bn	1.07 Bn
5	Encompass Health	10.07 Bn	10.70 Bn	1.34 Bn
6	Ensign	9.52 Bn	8.93 Bn	293.37 Mn
7	Universal Health Services	9.19 Bn	9.15 Bn	3.21 Bn
8	Pacs	6.96 Bn	6.72 Bn	345.96 Mn
9	Ww International	6.14 Bn	5.98 Bn	-149.29 Mn
10	BioCorRx	10,406.16	-374,763.84	189,355.00

Download Data